Accu-Chek Aviva II Meter - Product Usage: a. The Accu-Chek Aviva Plus Blood Glucose Monitoring Sy...

FDA Device Recall #Z-2765-2019 — Class II — June 12, 2017

Recall Summary

Recall Number Z-2765-2019
Classification Class II — Moderate risk
Date Initiated June 12, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diabetes Care, Inc.
Location Indianapolis, IN
Product Type Devices
Quantity 26,600

Product Description

Accu-Chek Aviva II Meter - Product Usage: a. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. b. The Accu-Chek Aviva Plus Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control. The Accu-Chek Aviva Plus Blood Glucose Monitoring System should not be used for the diagnosis of or screening of diabetes or for neonatal use. Alternative site testing should be done only during steady state times (when glucose is not changing rapidly). c. The Accu-Chek Aviva Plus Test Strips are for use with the Accu-Chek Aviva Blood Glucose Meter to quantitatively measure glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm.

Reason for Recall

Meters may contain a damaged C29 capacitor resulting in issues with power allegation (short battery life or meter not turning on).

Distribution Pattern

Worldwide distribution - US Nationwide distribution.

Lot / Code Information

Serial numbers between xxx20000000 and xxx23284925, or less than xxx06335297 Updated serial numbers on 10/12/2019: Aviva II: Between XXX20000000 and XXX23284925 Updated 10/18/2019: Aviva II from XXX05000001 to XXX06335297 OR from XXX20000000 to XXX23284925

Other Recalls from Roche Diabetes Care, Inc.

Recall # Classification Product Date
Z-2174-2024 Class II Accu-Chek Guide (SC) Kit -Intended to quantitat... May 13, 2024
Z-1008-2022 Class II RocheDiabetes Care Platform Software version 2.... Mar 9, 2022
Z-2351-2021 Class II Accu-Chek Aviva Plus Test Strip, Blood Glucose ... Jul 28, 2021
Z-2353-2021 Class II Accu-Chek SmartView Test Strip, Blood Glucose M... Jul 28, 2021
Z-2352-2021 Class II Accu-Chek Performa Test Strip, Blood Glucose Mo... Jul 28, 2021

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.